Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 56,714 | 62,038 | 52,813 | 57,925 | 24,786 |
| Marketable Securities | N/A | N/A | N/A | 10,000 | 10,000 |
| Receivables | 441 | 263 | 103 | 287 | 284 |
| TOTAL | $59,417 | $65,034 | $54,608 | $70,346 | $37,479 |
| Non-Current Assets | |||||
| PPE Net | 19,993 | 15,158 | 15,194 | 14,314 | 14,072 |
| Investments And Advances | 240 | 240 | 240 | 240 | 240 |
| Intangibles | 15,548 | 15,938 | 15,650 | 15,832 | 19,218 |
| Other Non-Current Assets | 22,490 | 24,969 | 21,890 | 5,684 | 4,806 |
| TOTAL | $58,270 | $56,305 | $52,974 | $36,070 | $38,336 |
| Total Assets | $117,687 | $121,339 | $107,581 | $106,415 | $75,815 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 14,546 | 6,132 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,352 | 869 | 423 | 484 | 388 |
| Accrued Expenses | 1,058 | 1,895 | 1,879 | 1,457 | 1,079 |
| Other current liabilities | 5,186 | 5,763 | 5,711 | 3,961 | 3,301 |
| TOTAL | $22,172 | $14,687 | $8,041 | $5,931 | $4,796 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 13,339 | 14,142 | 14,322 | 441 | 88 |
| TOTAL | $13,339 | $14,142 | $14,322 | $441 | $88 |
| Total Liabilities | $35,510 | $28,828 | $22,363 | $6,372 | $4,883 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,253 | 19,229 | 18,081 | 18,397 | 16,962 |
| Common Shares | 20 | 20 | 19 | 19 | 18 |
| Retained earnings | -171,416 | -159,319 | -149,983 | -141,463 | -128,720 |
| Other shareholders' equity | -1,461 | -1,066 | -1,423 | -1,040 | -206 |
| TOTAL | $82,177 | $92,511 | $85,218 | $100,043 | $70,932 |
| Total Liabilities And Equity | $117,687 | $121,339 | $107,581 | $106,415 | $75,815 |